Literature DB >> 2136815

Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome.

P Grande1, A M Grauholt, J K Madsen.   

Abstract

Platelet behavior was compared in two groups of patients with unstable angina: 13 patients with rest pain and ST depression on the electrocardiogram (the intermediate coronary syndrome), 14 patients with progressive angina without rest pain, and 20 healthy controls. Both patient groups had hyperaggregating platelets when compared with the controls (p less than 0.01). Platelet aggregation was measured ex vivo in the presence of arachidonic acid. Serum thromboxane B2, plasma beta-thromboglobulin, and platelet factor 4 were all temporarily increased in the group with intermediate coronary syndrome (p less than 0.01), whereas measurements in patients with progressive angina were not significantly different from the controls. Thus, patients with the intermediate coronary syndrome, who have a high frequency of suboccluding coronary artery thrombus and a very serious prognosis, had severely altered platelet behavior in contrast to patients with progressive angina.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136815

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

Review 1.  Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease?

Authors:  Wei Jiang; Ranga R Krishnan
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

2.  Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT(3) receptors.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

3.  Blockade of the human platelet GPIIb/IIIa receptor by a murine monoclonal antibody Fab fragment (7E3): potent dose-dependent inhibition of platelet function.

Authors:  S Bhattacharya; R Jordan; S Machin; R Senior; I Mackie; C R Smith; T F Schaible; H F Weisman; A Lahiri
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

Review 4.  Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target.

Authors:  Melanie Ziegler; Xiaowei Wang; Karlheinz Peter
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

5.  P-selectin (CD62P) and soluble TREM-like transcript-1 (sTLT-1) are associated with coronary artery disease: a case control study.

Authors:  Li Shen; Tianlun Yang; Ke Xia; Zhiqiang Yan; Juanjuan Tan; Lei Li; Yingchun Qin; Wei Shi
Journal:  BMC Cardiovasc Disord       Date:  2020-08-24       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.